Trial intelligence / Profile preview

Inhaled epinephrine to facilitate extubation in preterm neonates

IRCT20210607051507N4Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of epinephrine in respiratory distress syndrome (RDS), respiratory failure and preterm birth, sponsored by Tehran University of Medical Sciences. Started Nov 2021; status: completed.

02

Drugs

epinephrine
03

Conditions

respiratory distress syndrome (RDS)respiratory failurepreterm birth

Beyond the preview

Go deeper on IRCT20210607051507N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210607051507N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call